Preclinical studies demonstrated that GLP-1RAs attenuate experimental ALI in mice (Zhu et al
"Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions." Life Sciences
If your insurance doesnt cover the treatment, we can discuss affordable self-pay options and alternative therapies, such as lipotropic B12 injections, to help you achieve your goals
"We know that's a lot of inappropriate care that happens in Canada," said study co-author Dr
The study can inform policy changes that expand insurance coverage for GLP-1 drugs across a wider range of insurance plans, employment industries, income levels, sex, and other factors